The abstract is read at the publisher; the summary is JClub's.
PROFET reconstructs continuous, nonlinear gene-expression trajectories from sparsely sampled scRNA-seq time series, achieving 2.6–12.5× lower prediction error than ten trajectory-inference methods across mouse, human, and axolotl datasets.
- Why it matters: Static scRNA-seq snapshots limit inference of how cell states change over time, especially for understanding heterogeneity in development, regeneration, and therapy response.
- What they did: The particle-based gradient-flow framework uses simulation-free force matching to infer continuous dynamics from sparse single-cell time series, then was benchmarked on mouse, human in vitro, and in vivo axolotl regeneration datasets.
- The result: In palbociclib-treated MCF7 and three breast cancer patient datasets, PROFET reconstructed treatment-response trajectories and found a resistant subpopulation with large phenotypic shifts and enrichment of UNC5B, TLR3, PCDH19, PROCR, SLITRK6, and SEMA6B.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.